Genetic
Conventional plus UC-MSC treatment
Total Trials
4
Max Phase
—
Type
GENETIC
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Other(4)
Detailed Status
unknown4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
unknown4100%
Recent Activity
0 active trials
Showing 4 of 4
unknownphase_1
Safety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver Failure
NCT01844063
unknownphase_1
Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis
NCT01662973
unknownphase_1
Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis
NCT01661842
unknownphase_1
Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Plasma Exchange for Patients With Liver Failure
NCT01724398
Clinical Trials (4)
Showing 4 of 4 trials
NCT01844063Phase 1
Safety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver Failure
NCT01662973Phase 1
Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis
NCT01661842Phase 1
Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis
NCT01724398Phase 1
Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Plasma Exchange for Patients With Liver Failure
All 4 trials loaded
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 4